{"id":816573,"date":"2025-02-24T06:51:42","date_gmt":"2025-02-24T11:51:42","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-report-fourth-quarter-and-full-year-2024-financial-results-and-corporate-update-on-march-10-2025\/"},"modified":"2025-02-24T06:51:42","modified_gmt":"2025-02-24T11:51:42","slug":"biontech-to-report-fourth-quarter-and-full-year-2024-financial-results-and-corporate-update-on-march-10-2025","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-report-fourth-quarter-and-full-year-2024-financial-results-and-corporate-update-on-march-10-2025\/","title":{"rendered":"BioNTech to Report Fourth Quarter and Full Year 2024 Financial Results and Corporate Update on March 10, 2025"},"content":{"rendered":"<div class=\"mw_release\">\n<p>\n        <b>MAINZ, Germany, February 24, 2025 (GLOBE NEWSWIRE)<\/b> &#8212;\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=xDO7VJhmdilVu4mWcCajtP3_BeG2QIUpzBTi3NVqYcxOBPu7YyRIz-KTWIyZzEUK-GollIlJqTT4XCZ3U4brZcP2Enuc-S-Z7tL_amv1TVw=\" rel=\"nofollow\" target=\"_blank\">BioNTech SE<\/a> (Nasdaq: BNTX, \u201cBioNTech\u201d or \u201cthe Company\u201d) will announce its financial results for the fourth quarter and full year 2024 on Monday, March 10, 2025. Additionally, the Company will host a conference call and webcast that day at 8:00 a.m. EDT (1:00 p.m. CET) for investors, financial analysts and the general public to discuss its financial results and provide a corporate update.<\/p>\n<p align=\"justify\">To access the live conference call via telephone, please register via this <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=SIkpxMZulGaXSfB86tG6pkML6nZOovFzIIK0BU9h1eJ-J1JZsveeACLNzqZ5vOmogi0eMWz1tkCGTuroBziRbB-bqXUBLis5bXdZgrZC4oYSLBbFEYWO-2v7kHADFgxXrIMhuyJyFCxu0AdgCIDOew==\" rel=\"nofollow\" target=\"_blank\">link<\/a>. Once registered, dial-in numbers and a PIN will be provided. It is recommended to register at least one day in advance. The slide presentation and audio of the webcast will be available via this <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=SIkpxMZulGaXSfB86tG6prVlWKyckea3XKhcu19NxFPzsiQf3kDnRrz5Vuy714wWN8c5aZe7n4YKjE5aShzm7FHeVOrUXIVWrWmkdjPjTsU=\" rel=\"nofollow\" target=\"_blank\">link<\/a>.\u00a0 <\/p>\n<p align=\"justify\">Participants may also access the slides and the webcast of the conference call via the \u201cEvents &amp; Presentations\u201d page in the Investor Relations section of the Company\u2019s website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Np_HPIEee4ZrXmXHJVR1SUBbzxf19YYjBd5ECzjXfU7u09_PLTbdLiPh2uXhFfJDSaFWy_F86F8llepycB_v0pTp6slkXbSMGqPCofqhdm59cNLZ0-FHeOaPWeDXkWVS\" rel=\"nofollow\" target=\"_blank\">www.BioNTech.com<\/a>. A replay of the webcast will be made available shortly after the call and archived on the Company\u2019s website for 30 days following the call.<\/p>\n<p>\n        <b>About BioNTech<\/b>\n      <\/p>\n<p align=\"justify\">Biopharmaceutical New Technologies (BioNTech) is a global next generation immunotherapy company pioneering novel investigative therapies for cancer and other serious diseases. BioNTech exploits a wide array of computational discovery and therapeutic drug platforms with the intent of rapid development of novel biopharmaceuticals. Its broad portfolio of oncology product candidates includes individualized and off-the-shelf mRNA-based therapies, innovative chimeric antigen receptor (CAR) T cells, several protein-based therapeutics, including bispecific immune checkpoint modulators, targeted cancer antibodies and antibody-drug conjugate (ADC) therapeutics, as well as small molecules. Based on its deep expertise in mRNA vaccine development and in-house manufacturing capabilities, BioNTech and its collaborators are researching and developing multiple mRNA vaccine candidates for a range of infectious diseases alongside its diverse oncology pipeline. BioNTech has established a broad set of relationships with multiple global and specialized pharmaceutical collaborators, including DualityBio, Fosun Pharma, Genentech, a member of the Roche Group, Genevant, Genmab, MediLink, OncoC4, Pfizer and Regeneron. <\/p>\n<p>For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Np_HPIEee4ZrXmXHJVR1ScfTaJu-_K2T1FevMy1LO0DQRQxU9GHJjF5Hk7fw_kD_Mjk1muv_45SIN1j_-urGRZazm-vVW5yICOgW7bQC71c=\" rel=\"nofollow\" target=\"_blank\">www.BioNTech.com<\/a>.<br \/><b><br \/> CONTACTS<\/b><\/p>\n<p>\n        <b>Investor Relations<\/b><br \/>\n        <br \/>Michael Horowicz<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=AQi9-f7JQkq4RO333jiGc_vUC-O-uCC_IIJJCXAfn9wGj65dwL5-LSqeihL4QApEgkbTepqbgi90ZPB3yReMbF2UPI2hNpKAYoHLJ-98kSc=\" rel=\"nofollow\" target=\"_blank\">Investors@biontech.de<\/a><\/p>\n<p>\n        <b>Media Relations<br \/><\/b>Jasmina Alatovic<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-DFR5gW1hR6OQiipqRi6RTXQ0HMeScr2EYNligHM0qGlVhVXxf-dF_-H9SXR8CIA6gJEMqtlJ8MdN_zGXkt4bg02nHXy0pAW5kHbqsUJNvSskXVxHJ85uz9qe4ahF3dBnUztmfpxLJQ1u6RZ-IY9juL4PF771KnRXdT5GGkWK7icOJ1hBAbxYJVfnXTtoyvotmsEBza3XPYCDTEGTBZt9MQXdosZO-dqW7OazRh0mkSA9512qJ1tI50gOEm7njA-nZOm99jVJTQzquaf_Cl8Zw==\" rel=\"nofollow\" target=\"_blank\">Media@biontech.de<\/a><\/p>\n<p>\n        <br \/>\u00a0<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTA1MDEyMiM0MDIwNjUzMTIjMjAwMDk4NQ==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml-eu.globenewswire.com\/media\/YjEzNzRkZGEtOTI2ZC00MTk4LWIyMjktNTE1ZmVmYTI1ODdkLTEwMTI1NTg=\/tiny\/BioNTech-SE.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>MAINZ, Germany, February 24, 2025 (GLOBE NEWSWIRE) &#8212;\u00a0BioNTech SE (Nasdaq: BNTX, \u201cBioNTech\u201d or \u201cthe Company\u201d) will announce its financial results for the fourth quarter and full year 2024 on Monday, March 10, 2025. Additionally, the Company will host a conference call and webcast that day at 8:00 a.m. EDT (1:00 p.m. CET) for investors, financial analysts and the general public to discuss its financial results and provide a corporate update. To access the live conference call via telephone, please register via this link. Once registered, dial-in numbers and a PIN will be provided. It is recommended to register at least one day in advance. The slide presentation and audio of the webcast will be available via this link.\u00a0 Participants may &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-report-fourth-quarter-and-full-year-2024-financial-results-and-corporate-update-on-march-10-2025\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;BioNTech to Report Fourth Quarter and Full Year 2024 Financial Results and Corporate Update on March 10, 2025&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-816573","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>BioNTech to Report Fourth Quarter and Full Year 2024 Financial Results and Corporate Update on March 10, 2025 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-report-fourth-quarter-and-full-year-2024-financial-results-and-corporate-update-on-march-10-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BioNTech to Report Fourth Quarter and Full Year 2024 Financial Results and Corporate Update on March 10, 2025 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"MAINZ, Germany, February 24, 2025 (GLOBE NEWSWIRE) &#8212;\u00a0BioNTech SE (Nasdaq: BNTX, \u201cBioNTech\u201d or \u201cthe Company\u201d) will announce its financial results for the fourth quarter and full year 2024 on Monday, March 10, 2025. Additionally, the Company will host a conference call and webcast that day at 8:00 a.m. EDT (1:00 p.m. CET) for investors, financial analysts and the general public to discuss its financial results and provide a corporate update. To access the live conference call via telephone, please register via this link. Once registered, dial-in numbers and a PIN will be provided. It is recommended to register at least one day in advance. The slide presentation and audio of the webcast will be available via this link.\u00a0 Participants may &hellip; Continue reading &quot;BioNTech to Report Fourth Quarter and Full Year 2024 Financial Results and Corporate Update on March 10, 2025&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-report-fourth-quarter-and-full-year-2024-financial-results-and-corporate-update-on-march-10-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-24T11:51:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTA1MDEyMiM0MDIwNjUzMTIjMjAwMDk4NQ==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biontech-to-report-fourth-quarter-and-full-year-2024-financial-results-and-corporate-update-on-march-10-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biontech-to-report-fourth-quarter-and-full-year-2024-financial-results-and-corporate-update-on-march-10-2025\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"BioNTech to Report Fourth Quarter and Full Year 2024 Financial Results and Corporate Update on March 10, 2025\",\"datePublished\":\"2025-02-24T11:51:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biontech-to-report-fourth-quarter-and-full-year-2024-financial-results-and-corporate-update-on-march-10-2025\\\/\"},\"wordCount\":364,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biontech-to-report-fourth-quarter-and-full-year-2024-financial-results-and-corporate-update-on-march-10-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTA1MDEyMiM0MDIwNjUzMTIjMjAwMDk4NQ==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biontech-to-report-fourth-quarter-and-full-year-2024-financial-results-and-corporate-update-on-march-10-2025\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biontech-to-report-fourth-quarter-and-full-year-2024-financial-results-and-corporate-update-on-march-10-2025\\\/\",\"name\":\"BioNTech to Report Fourth Quarter and Full Year 2024 Financial Results and Corporate Update on March 10, 2025 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biontech-to-report-fourth-quarter-and-full-year-2024-financial-results-and-corporate-update-on-march-10-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biontech-to-report-fourth-quarter-and-full-year-2024-financial-results-and-corporate-update-on-march-10-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTA1MDEyMiM0MDIwNjUzMTIjMjAwMDk4NQ==\",\"datePublished\":\"2025-02-24T11:51:42+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biontech-to-report-fourth-quarter-and-full-year-2024-financial-results-and-corporate-update-on-march-10-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biontech-to-report-fourth-quarter-and-full-year-2024-financial-results-and-corporate-update-on-march-10-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biontech-to-report-fourth-quarter-and-full-year-2024-financial-results-and-corporate-update-on-march-10-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTA1MDEyMiM0MDIwNjUzMTIjMjAwMDk4NQ==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTA1MDEyMiM0MDIwNjUzMTIjMjAwMDk4NQ==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biontech-to-report-fourth-quarter-and-full-year-2024-financial-results-and-corporate-update-on-march-10-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BioNTech to Report Fourth Quarter and Full Year 2024 Financial Results and Corporate Update on March 10, 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BioNTech to Report Fourth Quarter and Full Year 2024 Financial Results and Corporate Update on March 10, 2025 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-report-fourth-quarter-and-full-year-2024-financial-results-and-corporate-update-on-march-10-2025\/","og_locale":"en_US","og_type":"article","og_title":"BioNTech to Report Fourth Quarter and Full Year 2024 Financial Results and Corporate Update on March 10, 2025 - Market Newsdesk","og_description":"MAINZ, Germany, February 24, 2025 (GLOBE NEWSWIRE) &#8212;\u00a0BioNTech SE (Nasdaq: BNTX, \u201cBioNTech\u201d or \u201cthe Company\u201d) will announce its financial results for the fourth quarter and full year 2024 on Monday, March 10, 2025. Additionally, the Company will host a conference call and webcast that day at 8:00 a.m. EDT (1:00 p.m. CET) for investors, financial analysts and the general public to discuss its financial results and provide a corporate update. To access the live conference call via telephone, please register via this link. Once registered, dial-in numbers and a PIN will be provided. It is recommended to register at least one day in advance. The slide presentation and audio of the webcast will be available via this link.\u00a0 Participants may &hellip; Continue reading \"BioNTech to Report Fourth Quarter and Full Year 2024 Financial Results and Corporate Update on March 10, 2025\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-report-fourth-quarter-and-full-year-2024-financial-results-and-corporate-update-on-march-10-2025\/","og_site_name":"Market Newsdesk","article_published_time":"2025-02-24T11:51:42+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTA1MDEyMiM0MDIwNjUzMTIjMjAwMDk4NQ==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-report-fourth-quarter-and-full-year-2024-financial-results-and-corporate-update-on-march-10-2025\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-report-fourth-quarter-and-full-year-2024-financial-results-and-corporate-update-on-march-10-2025\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"BioNTech to Report Fourth Quarter and Full Year 2024 Financial Results and Corporate Update on March 10, 2025","datePublished":"2025-02-24T11:51:42+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-report-fourth-quarter-and-full-year-2024-financial-results-and-corporate-update-on-march-10-2025\/"},"wordCount":364,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-report-fourth-quarter-and-full-year-2024-financial-results-and-corporate-update-on-march-10-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTA1MDEyMiM0MDIwNjUzMTIjMjAwMDk4NQ==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-report-fourth-quarter-and-full-year-2024-financial-results-and-corporate-update-on-march-10-2025\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-report-fourth-quarter-and-full-year-2024-financial-results-and-corporate-update-on-march-10-2025\/","name":"BioNTech to Report Fourth Quarter and Full Year 2024 Financial Results and Corporate Update on March 10, 2025 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-report-fourth-quarter-and-full-year-2024-financial-results-and-corporate-update-on-march-10-2025\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-report-fourth-quarter-and-full-year-2024-financial-results-and-corporate-update-on-march-10-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTA1MDEyMiM0MDIwNjUzMTIjMjAwMDk4NQ==","datePublished":"2025-02-24T11:51:42+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-report-fourth-quarter-and-full-year-2024-financial-results-and-corporate-update-on-march-10-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-report-fourth-quarter-and-full-year-2024-financial-results-and-corporate-update-on-march-10-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-report-fourth-quarter-and-full-year-2024-financial-results-and-corporate-update-on-march-10-2025\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTA1MDEyMiM0MDIwNjUzMTIjMjAwMDk4NQ==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTA1MDEyMiM0MDIwNjUzMTIjMjAwMDk4NQ=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-report-fourth-quarter-and-full-year-2024-financial-results-and-corporate-update-on-march-10-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"BioNTech to Report Fourth Quarter and Full Year 2024 Financial Results and Corporate Update on March 10, 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/816573","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=816573"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/816573\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=816573"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=816573"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=816573"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}